MGRM - Monogram Orthopedics Inc. Long-Term Liabilities to Capital

Symbol and logo of brand Monogram Orthopedics Inc. (MGRM)

The success of Monogram Technologies (MGRM) is based on FDA approval of new products and the pace of surgical robotization. Monogram Technologies (MGRM) stabilizes revenues by combining the sale of high-cost systems with the supply of joint consumables. Development relies on working with distributors without mergers. The indicator is 0.02. Stock price fluctuations on the GURU.Markets platform clearly demonstrate the current dynamics of this medical technology startup.

Monogram Technologies Inc (MGRM): Long-Term Debt to Capital from 02/21/2024 to 10/18/2025

Comprehensive metric breakdowns and analytics for Monogram Technologies (MGRM)

- price and consensus price forecast:
Stock Quotes Monogram Technologies Inc.|MGRM - Analyst Consensus Forecast
- market capitalization data:
Market Value Monogram Technologies|MGRM - Enterprise Value
- book capitalization data:
Equity per Share Monogram Orthopedics|MGRM - Book Capitalization|Market Capitalization to Book Value monogramorthopedics.com|MGRM - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Monogram Technologies|MGRM - Long-Term Debt to Capital|Short-Term Debt to Capital monogramorthopedics.com|MGRM - Company Debts|Debt to Book Capitalization Ratio Monogram Technologies
Comprehensive company analysis:MGRM Monogram Technologies Inc.
Core merchandise of Monogram Technologies

This ratio determines the proportion of long-term liabilities within the equity structure, allowing for an assessment of financial stability and the risk of excessive leverage. By analyzing the long-term debt-to-equity ratio, an investor can understand how aggressively Monogram Technologies (MGRM) is financing its expansion into the robotic orthopedics market and its capture of the hospital sector's market share through borrowed funds.

Competitor analysis

Long-Term Debt to Equity Ratio Intuitive Surgical, Inc.|Danaher Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Becton Dickinson & Company (BDX)|STE - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio westpharma.com WST|Long-Term Debt to Capital BAX (Baxter)|MASI - Ratio of Long-Term Indebtedness to Capital|STVN (Stevanato) - Long-Term Debt to Capital|Teleflex Corp (TFX) - Long-Term Debt to Equity Ratio|MMSI (Merit Medical Systems) - Long-Term Debt to Capital|Long-Term Debt to Capital NVST|Long-Term Debt to Equity ICU Medical (ICUI)|Long-Term Debt to Equity Dentsply Sirona Inc XRAY|Long-Term Debt to Equity Ratio LeMaitre|Long-Term Debt to Capital Coefficient AtriCure Medical ATRC|Long-Term Debt to Capital STAA (STAAR Surgical Company)|NAGE: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity ZimVie|ANGO (AngioDynamics Inc) - Long-Term Debt to Capital Ratio|CERS: Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Teknova Inc (TKNO)|Long-Term Debt to Equity Ratio Sharps Technology, Inc.|Long-Term Loans to Capital Ratio INFU (infusystem.com)|Long-Term Debt to Equity Utah Medical Products, Inc.|KRMD - Long-Term Debt to Capital Coefficient|Nyxoah, S.A. - Long-Term Debt to Equity Ratio|MBOT: Long-Term Debt to Capital|PDEX (Pro-Dex, Inc.) - Long-Term Debt to Equity|zentek.com (ZTEK) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital ELUT (Elutia)|Long-Term Liabilities to Capital MLSS|Long-Term Debt to Equity NEXGEL, Inc NXGL|Long-Term Debt to Capital Ratio retractable.com RVP|Long-Term Debt to Equity Ratio Harvard Bioscience, Inc. (HBIO)|femasys.com - Long-Term Loans to Capital Ratio|Long-Term Debt to Equity MHUA (Meihua Medical)|POAI: Ratio of Long-Term Indebtedness to Capital|CJMB (callanjmb.com) - Long-Term Debt to Equity|ATRI (Atrion Corporation Inc.) - Long-Term Debt to Equity Ratio|Long-Term Debt to Equity NURO (NeuroMetrix, Inc.)